These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33849461)

  • 1. European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults.
    Méroc E; Fröberg J; Almasi T; Winje BA; Orrico-Sánchez A; Steens A; McDonald SA; Bollaerts K; Knol MJ
    BMC Infect Dis; 2021 Apr; 21(1):345. PubMed ID: 33849461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.
    van Lier A; de Gier B; McDonald SA; Mangen MJ; van Wijhe M; Sanders EAM; Kretzschmar ME; van Vliet H; de Melker HE
    Euro Surveill; 2019 May; 24(18):. PubMed ID: 31064637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of foodborne burden of disease studies: quality assessment of data and methodology.
    Haagsma JA; Polinder S; Stein CE; Havelaar AH
    Int J Food Microbiol; 2013 Aug; 166(1):34-47. PubMed ID: 23827806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016.
    Charania NA; Gaze N; Kung JY; Brooks S
    Vaccine; 2019 May; 37(20):2661-2669. PubMed ID: 30967311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological considerations in injury burden of disease studies across Europe: a systematic literature review.
    Charalampous P; Pallari E; Gorasso V; von der Lippe E; Devleesschauwer B; Pires SM; Plass D; Idavain J; Ngwa CH; Noguer I; Padron-Monedero A; Sarmiento R; Majdan M; Ádám B; AlKerwi A; Cilovic-Lagarija S; Clarsen B; Corso B; Cuschieri S; Dopelt K; Economou M; Fischer F; Freitas A; García-González JM; Gazzelloni F; Gkitakou A; Gulmez H; Hynds P; Isola G; Jakobsen LS; Kabir Z; Kissimova-Skarbek K; Knudsen AK; Konar NM; Ladeira C; Lassen B; Liew A; Majer M; Mechili EA; Mereke A; Monasta L; Mondello S; Morgado JN; Nena E; Ng ESW; Niranjan V; Nola IA; O'Caoimh R; Petrou P; Pinheiro V; Ortiz MR; Riva S; Samouda H; Santos JV; Santoso CMA; Milicevic MS; Skempes D; Sousa AC; Speybroeck N; Tozija F; Unim B; Uysal HB; Vaccaro FG; Varga O; Vasic M; Violante FS; Wyper GMA; Polinder S; Haagsma JA
    BMC Public Health; 2022 Aug; 22(1):1564. PubMed ID: 35978333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices.
    Charalampous P; Gorasso V; Plass D; Pires SM; von der Lippe E; Mereke A; Idavain J; Kissimova-Skarbek K; Morgado JN; Ngwa CH; Noguer I; Padron-Monedero A; Santi-Cano MJ; Sarmiento R; Devleesschauwer B; Haagsma JA;
    Eur J Public Health; 2022 Apr; 32(2):289-296. PubMed ID: 35015851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of vaccine preventable disease surveillance cost studies.
    Erondu NA; Ferland L; Haile BH; Abimbola T
    Vaccine; 2019 Apr; 37(17):2311-2321. PubMed ID: 30902482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
    McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
    J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conducting national burden of disease studies in small countries in Europe- a feasible challenge?
    Cuschieri S; Pallari E; Terzic N; Alkerwi A; Sigurvinsdottir R; Sigfusdottir ID; Devleesschauwer B
    Arch Public Health; 2021 May; 79(1):73. PubMed ID: 33971960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.
    O'Brien KL; Wolfson LJ; Watt JP; Henkle E; Deloria-Knoll M; McCall N; Lee E; Mulholland K; Levine OS; Cherian T;
    Lancet; 2009 Sep; 374(9693):893-902. PubMed ID: 19748398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.
    Chalmers JD; Campling J; Dicker A; Woodhead M; Madhava H
    BMC Pulm Med; 2016 May; 16(1):77. PubMed ID: 27169895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis.
    Vinsard DG; Wakefield D; Vaziri H; Karagozian R
    Inflamm Bowel Dis; 2019 Nov; 25(12):1966-1973. PubMed ID: 31067308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
    Mangen MJ; Bouwknegt M; Friesema IH; Haagsma JA; Kortbeek LM; Tariq L; Wilson M; van Pelt W; Havelaar AH
    Int J Food Microbiol; 2015 Mar; 196():84-93. PubMed ID: 25528537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
    Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
    Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of vaccine-preventable diseases among at-risk adult populations in the US.
    Kolobova I; Nyaku MK; Karakusevic A; Bridge D; Fotheringham I; O'Brien M
    Hum Vaccin Immunother; 2022 Nov; 18(5):2054602. PubMed ID: 35446725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of disease, disability-adjusted life years and frailty prevalence.
    O'Donovan MR; Sezgin D; Liew A; O'Caoimh R
    QJM; 2019 Apr; 112(4):261-267. PubMed ID: 30541151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of the pneumococcal vaccine in healthy younger adults.
    Pepper PV; Owens DK
    Med Decis Making; 2002; 22(5 Suppl):S45-57. PubMed ID: 12369231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.
    Evers SM; Ament AJ; Colombo GL; Konradsen HB; Reinert RR; Sauerland D; Wittrup-Jensen K; Loiseau C; Fedson DS
    Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):531-40. PubMed ID: 17570001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis.
    Adetokunboh OO; Awotiwon A; Ndwandwe D; Uthman OA; Wiysonge CS
    Hum Vaccin Immunother; 2019; 15(11):2590-2605. PubMed ID: 30945963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea.
    Choi MJ; Kang SO; Oh JJ; Park SB; Kim MJ; Cheong HJ
    Hum Vaccin Immunother; 2018; 14(8):1914-1922. PubMed ID: 29953307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.